Latest Breaking News On - Director yadin rozov - Page 1 : comparemela.com

Insider Buying: Neo Performance Materials Inc (TSE:NEO) Director Buys 8,900 Shares of Stock

Insider Buying: Neo Performance Materials Inc (TSE:NEO) Director Buys 8,900 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel nicolausRaymond jamesYadin rozovNeo performance materials incNeo performance materialsGet free reportDirector yadin rozovPerformance materialsPerformance materials incNeo performance materials daily

Landscape Capital Management L L C Acquires New Stake in Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

Landscape Capital Management L.L.C. acquired a new position in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 26,220 shares of the biotechnology company’s stock, valued at approximately $315,000. Landscape Capital Management L.L.C. owned […]

Yadin rozovNadav kidronRenaissance technologiesOramed pharmaceuticalsQuarter for oramed pharmaceuticalsOramed pharmaceuticals profileMillennium managementBlackrock incOramed pharmaceuticals incSecurities exchange commissionLindbrook capitalOramed pharmaceuticals trading downNews ratings for oramed pharmaceuticals dailyGet ratingStreet corpDirector yadin rozov

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Cross Below 200 Day Moving Average of $4 88

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $4.88 and traded as low as $2.81. Oramed Pharmaceuticals shares last traded at $3.03, with a volume of 740,289 shares trading hands. Wall Street Analyst Weigh In ORMP […]

Hong kongYadin rozovNadav kidronJanney montgomery scottCantor fitzgeraldOramed pharmaceuticals incNews ratings for oramed pharmaceuticals dailyHong kong ltdOramed pharmaceuticalsAdvisor groupOramed pharmaceuticals stock downSecurities exchange commissionCanaccord genuity groupGet ratingGenuity groupPharmaceuticals stock down

Oramed Pharmaceuticals (NASDAQ:ORMP) Rating Increased to Hold at StockNews com

StockNews.com upgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday morning. Other analysts have also recently issued research reports about the stock. Canaccord Genuity Group cut shares of Oramed Pharmaceuticals from a buy rating to a hold rating and cut their […]

Nadav kidronYadin rozovManagers groupOramed pharmaceuticals incSecurities exchange commissionCapital managementOramed pharmaceuticals stockOramed pharmaceuticalsCanaccord genuity groupCantor fitzgeraldNews ratings for oramed pharmaceuticals dailyOramed pharmaceuticals company profileInstitutional trading of oramed pharmaceuticalsAltshuler shaham ltdMarshall waceGet rating

Short Interest in Oramed Pharmaceuticals Inc (NASDAQ:ORMP) Drops By 19 9%

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 789,300 shares, a decline of 19.9% from the March 15th total of 985,700 shares. Based on an average trading volume of 1,690,000 shares, the days-to-cover ratio is […]

Hong kongNadav kidronYadin rozovCanaccord genuity groupCantor fitzgeraldNews ratings for oramed pharmaceuticals dailyOramed pharmaceuticalsOramed pharmaceuticals incAdvisor groupHong kong ltdJanney montgomery scottHedge funds weigh in on oramed pharmaceuticalsOramed pharmaceuticals stock performanceGet ratingDirector yadin rozovKong ltd